Max Robotics — Global Service Robot Directory + US Certification

About

Monty Fricker is a urologic surgeon and researcher whose work centers on advancing the surgical management of prostate cancer, with a particular focus on robotic-assisted techniques and salvage therapies. His major contributions include pioneering comparative effectiveness studies that evaluate outcomes of salvage robot-assisted radical prostatectomy (sRARP) for locally recurrent prostate cancer following nonsurgical primary treatments. One of his key papers, a propensity-matched analysis from a high-volume tertiary center, demonstrated that sRARP can achieve comparable oncological outcomes to primary RARP, offering a critical treatment pathway for patients with recurrence. This work has garnered 28 citations, underscoring its clinical relevance. Fricker has also led innovative research on salvage radiotherapy versus salvage prostatectomy after focal or whole-gland ablative therapies, providing evidence-based guidance for complex decision-making. Beyond clinical outcomes, he has advanced surgical education through the VROBOT study, a randomized trial showing that virtual classroom training enhances proficiency in robotic surgery. Additionally, his recommendations to reduce unnecessary blood tests after robot-assisted radical prostatectomy have practical implications for postoperative care. Fricker’s research bridges surgical innovation, patient-centered outcomes, and training standardization, making him a notable figure in urologic oncology.